| Trial registration number
|
NCT04751721 |
Full text link
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04751721
|
First author
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Kadirhan Ozdemir
|
Contact
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-02-12
|
Recruitment status
Last imported at : Feb. 3, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Unknown
|
Study design
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
nonRCT
|
Allocation
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Non-randomized
|
Design
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Single group assignment
|
Masking
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Prevention
|
Inclusion criteria
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- agree to voluntarily participate in the study
|
Exclusion criteria
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
- have been taking trace element supplements for the past 2 weeks
- being pregnant
- body mass index over 40 kg/m2
- diagnosed with covid-19 in advance
- not diagnosed with any chronic disease
|
Number of arms
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
1
|
Funding
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Izmir Bakircay University
|
Inclusion age min
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
35
|
Inclusion age max
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
65
|
Countries
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Turkey
|
Type of patients
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Healthy volunteers
|
Severity scale
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
20
|
primary outcome
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Change of the levels of Oxidative Stress Parameter 1;Change of the levels of Oxidative Stress Parameter 2;Change of the levels of Oxidative Stress Parameter 3;Change of the levels of Oxidative Stress Parameter 4;Change of the levels of quality of life;Change of the levels serum trace element 1;Change of the levels serum trace element 2;Change of the levels serum trace element 3;Change of the levels serum trace element 4;Change of the levels serum trace element 5;Change of the levels serum trace element 6;Change of the levels serum trace element 7
|
Notes
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "2;day1-24", "treatment_id": 327, "treatment_name": "Coronavac", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}]
|